Endothelium-dependent flow-mediated vasodilation after salsalate therapy was impaired compared with placebo therapy in subjects with therapeutic salicylate levels ( n = 31 , P < 0.02 ) but not in subjects with subtherapeutic levels ( P > 0.2 ) .